Capital Analysts, LLC Gsk PLC Transaction History

Capital Analysts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $15,810 - $17,961	376 New	376 $16,000
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $16,454 - $19,525	-409 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$38.88 - $45.31 $155 - $181	4 Added 0.99%	409 $18,000
Q3 2021 Nov 04, 2021	SELL	$38.79 - $43.16 $18,192 - $20,242	-469 Reduced 53.66%	405 $15,000
Q2 2021 Aug 05, 2021	BUY	$36.52 - $41.46 $31,918 - $36,236	874 New	874 $35,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.